SCHEMBL24012361

SCHEMBL24012361

Cc1cc2ccc(OCC(=O)NCCOCCOCCOCCOCCC(=O)OCCc3ccc(O)cc3)cc2oc1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 4/20 0.48
▸ CA1 P00915 4/20 0.48
▸ CA2 P00918 4/20 0.48
▸ CA4 P22748 4/20 0.48
▸ CA5A P35218 4/20 0.48
▸ CA7 P43166 4/20 0.48
▸ CA5B Q9Y2D0 4/20 0.48
▸ MAOB P27338 3/20 0.44
▸ MAOA P21397 1/20 0.44
▸ KMT2A Q03164 3/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ NCF1 P14598 1/20 0.42
▸ SLC16A3 O15427 1/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ GLA P06280 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24012357 0.83 KMT2A (0.53) CA12CA1CA2CA4CA5A
SCHEMBL24012368 0.80 KMT2A (0.45) CA12CA1CA2CA4CA5A
Trifluoroacetic Acid SCHEMBL21806629 0.71 AKR1B10 (0.49) CA12CA1CA2CA4CA5A
SCHEMBL24012369 0.70 MAOB (0.45) CA12CA1CA2CA4CA5A
SCHEMBL11054587 0.70 KDM4E (0.76) CA12CA1CA2CA4CA5A
SCHEMBL25279702 0.69 AKR1B10 (0.75) CA12CA1CA2CA4CA5A
SCHEMBL25708668 0.68 AKR1B10 (0.77) CA12CA1CA2CA4CA5A
SCHEMBL21806631 0.67 CA12 (0.47) CA12CA1CA2CA4CA5A
SCHEMBL25235579 0.67 AKR1B10 (0.64) CA12CA1CA2CA4CA5A
SCHEMBL21806210 0.66 MAOB (0.46) CA12CA1CA2CA4CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210349101-A1 COUMARIN-BASED CROSSLINKING REAGENTS VENTANA MEDICAL SYSTEMS, INC. 2021-11-11 — — US disclosed
Send feedback